-
SFRP1, Wnt/β-Catenin, and Oral Fibrosis
2026-09-12
The reference study links reduced SFRP1 expression with neutrophil infiltration, fibrosis, and activation of canonical Wnt/β-catenin signaling in arecoline-induced oral submucous fibrosis. Its combination of tissue correlation, SFRP1 overexpression, and pathway-rescue experiments supports a mechanistic model in which SFRP1 restrains both inflammatory recruitment and fibrotic signaling, while remaining preliminary for clinical translation.
-
Cabazitaxel (XRP6258) Workflow Guide
2026-09-12
Cabazitaxel (XRP6258, SKU B2157) is a water-insoluble taxane derivative for studying microtubule dynamics disruption and antiproliferative responses, including in P-glycoprotein-expressing or taxane-resistant cancer models. It is suited to DMSO- or ethanol-based preparation, but should not be prepared directly in water or retained as a long-term solution.
-
Golgi-Tracker Green: Live-Cell Golgi Workflows
2026-09-11
Golgi-Tracker Green converts ceramide trafficking into a practical live-cell readout for Golgi structure, lipid movement, and sphingolipid metabolism. This workflow emphasizes solvent handling, pulse–chase design, photostable imaging, and cautious interpretation when connecting organelle stress to cancer biology.
-
Oligomycin A for Mitochondrial Bioenergetics
2026-09-11
Oligomycin A enables controlled separation of ATP-linked respiration from compensatory glycolysis, making it useful for mitochondrial bioenergetics research, cancer metabolism research, and apoptosis pathway study. This workflow also translates a recent macrophage immunometabolism finding into practical OCR, ROS, and phenotype assays.
-
Perospirone: Applied Assay Workflows
2026-09-10
Perospirone (SM-9018 free base) supports a two-axis research strategy: receptor pharmacology for schizophrenia research and electrophysiology for investigating vascular Kv channel modulation. This article converts its defined solubility, storage, and target profile into practical workflows with concentration planning, controls, and troubleshooting guidance.
-
ALT Cancer Cells and ATR Inhibition: What the Study Shows
2026-09-10
Deeg and colleagues tested whether alternative lengthening of telomeres (ALT) creates a general vulnerability to ATR inhibition and found that ALT-positive cells were not uniformly hypersensitive to VE-821. The study’s use of multiple cell lines and an inducible, isogenic ALT-suppression model shows why telomere-maintenance status should not be treated as a standalone predictor of ATR inhibitor response.
-
Cy5-UTP for Neuronal RNA Imaging Workflows
2026-09-09
Cy5-UTP converts T7-driven transcription into a direct, far-red RNA detection workflow for FISH, probe synthesis, and multicolor assays. This guide connects practical labeling choices with a recent neuronal trafficking study, while separating experimentally supported findings from optimization recommendations.
-
Cefodizime: In Vitro Workflows and Optimization
2026-09-09
Cefodizime supports reproducible studies of penicillin-binding protein inhibition, respiratory and urinary pathogen susceptibility, and antibiotic–host-cell interactions. This guide converts its spectrum, formulation constraints, and immunomodulatory potential into practical assay workflows with troubleshooting checkpoints.
-
Cyclosporin Variants: Structure and Mitochondrial Activity
2026-09-08
The 2020 reference study combined NMR spectroscopy, molecular dynamics, and calcium-dependent mitochondrial swelling assays to compare cyclosporins B–E with cyclosporin A. Its central finding was that three variants retained cyclosporin A-like inhibition of mitochondrial pore opening, whereas the structurally more rigid cyclosporin E was inactive at the tested concentrations, linking peptide flexibility with membrane-associated biological activity.
-
MK 0893 Workflow for GCGR Antagonism
2026-09-08
MK 0893 is a potent, reversible glucagon receptor antagonist for connecting GCGR binding, cAMP signaling, and glucose control in one research workflow. This guide translates its allosteric mechanism into practical cell-based, selectivity, and in vivo study designs with troubleshooting checkpoints.
-
Pronase E: From Digestion to Mechanistic Evidence
2026-09-07
Pronase E is a broad-spectrum protease mixture for converting complex protein samples into interpretable molecular evidence. This guide develops an assay-decision framework linking Pronase E sample preparation with mechanistic interpretation of the CUL3–MTDH ferroptosis pathway in triple-negative breast cancer research.
-
Urolithin A for Mitochondrial Quality Control
2026-09-05
Build a practical Urolithin A workflow that connects mitophagy, respiratory function, and metabolic remodeling with fibrosis-oriented assay design. The guide separates evidence-supported findings from hypothesis-generating applications, with dosing, controls, and troubleshooting for reproducible cell studies.
-
Palomid 529: A Pathway-Aware Assay Strategy
2026-09-05
Palomid 529 (P529) offers a distinctive way to test whether PI3K/Akt/mTOR signaling sustains ESCC metastasis and treatment resistance. This guide translates RCN2 mechanistic findings into rigorous pathway, angiogenesis, cisplatin, and radiotherapy assay decisions.
-
ATRX Deficiency Sensitizes Glioma to PDGFR Inhibitors
2026-09-04
Pladevall-Morera et al. used a drug-screening strategy to show that ATRX-deficient high-grade glioma cells are more vulnerable to selected receptor tyrosine kinase and PDGFR inhibitors than ATRX-proficient cells. The study also found pronounced toxicity when RTK inhibition was combined with temozolomide, supporting ATRX status as a variable for interpreting targeted-therapy studies.
-
Chemerin–cNTS Redox Signaling and Blood Pressure
2026-09-04
The reference study identifies a chemerin–CMKLR1–NADPH oxidase–superoxide pathway in the caudal nucleus tractus solitarius that increases sympathetic nerve activity, arterial pressure, and heart rate. Its circuit-level pharmacology further places NMDA receptor signaling in the paraventricular nucleus downstream of caudal NTS chemerin, while CNQX-sensitive AMPA/kainate transmission was not required under the tested conditions.